Standard Newswire is a cost-effective and efficient newswire service for public policy groups, government agencies, PR firms, think-tanks, watchdog groups, advocacy groups, coalitions, foundations, colleges, universities, activists, politicians, and candidates to distribute their press releases to journalists who truly want to hear from them.
Do not settle for an email blasting service or a newswire overloaded with financial statements. Standard Newswire gets your news into the hands of working journalists, broadcast hosts, and news producers.
Find out how you can start using Standard Newswire to
Do not settle for an email blasting service or a newswire overloaded with financial statements. Standard Newswire gets your news into the hands of working journalists, broadcast hosts, and news producers.
Find out how you can start using Standard Newswire to
Sign Up to Receive Press Releases:
Standard Newswire™ LLC
209 W. 29th Street, Suite 6202
New York, NY 10001, USA.
(212) 290-1585
Study of 36 Chinese Abortion-Breast Cancer Studies a 'Game Changer' Says Scientist
Two of three meta-analyses now support link between abortion and breast cancer.
Contact: Professor Joel Brind, 914-805-9215; Coalition on Abortion/Breast Cancer
HOFFMAN ESTATES, Ill., Dec. 2, 2013 /Standard Newswire/ -- A systematic review and meta-analysis of 36 Chinese studies by Dr. Yubei Huang and his colleagues in the prestigious journal, Cancer Causes Control, last week reported a significant 44% increased breast cancer risk among women with at least one induced abortion (IA), compared to women without IAs.[1] The risk increased with number of IAs (a dose effect), an important measure of a cause-effect relationship, with two and three IAs raising risk by a statistically significant 76% and 89%, respectively. Earlier studies also found a dose effect.[2,3,4,5]
Huang's team cited and supports a 1996 review and meta-analysis, led by Joel Brind, Ph.D. (Baruch College, City University of New York) (photo) and colleagues at Penn State[6], who found a 30% risk elevation for women with any history of IAs. Huang's team agreed with criticism from Drs. Brind and Vernon Chinchilli in the British Journal of Cancer[7] concerning two high profile Shanghai studies.[8,9]
In his analysis of the Chinese study (below), Brind called it a "game changer." He exclaimed, "Not only does it validate our earlier findings from 1996, but its findings are even stronger, for several reasons."
Significantly, Brind argued ObamaCare insurance funds abortion and contraceptive steroids (i.e. the Pill) which will be disastrous for women's health.
Huang's team said their results differed from those of a 2004 meta-analysis by Dr. Valerie Beral and her colleagues.[10] Their paper, which claimed there was no link, received harsh criticism in seven medical journals from four experts independently of one another.[11,12,13,14,15,16,17]
Karen Malec, president of the Coalition on Abortion/Breast Cancer, said, "Our organization and the Breast Cancer Prevention Institute (which Dr. Brind co-founded) are among the groups that collaborated on an amicus brief in three lawsuits against ObamaCare's contraceptive mandate.[18] Last month, a federal appellate court cited the brief which reports the World Health Organization's classification of the Pill as a Group 1 carcinogen; and the U.S. Supreme Court announced it would hear those lawsuits."[19]
The Coalition on Abortion/Breast Cancer is an international women's organization founded to protect the health and save the lives of women by educating and providing information on abortion as a risk factor for breast cancer.
References: Click here
